Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Vertex dedicates significant efforts to MDR-reversing agents

May 3, 1996

Receptagen will develop vitamin B12 uptake inhibitors

May 3, 1996

Somatix receives patent protection for novel glioma treatment

May 3, 1996

NSAID blocks carcinogenesis in rodent models

May 3, 1996

Targretin clinical trials update

May 3, 1996

Eisai presents preliminary data on ER-34335

May 3, 1996

AG-3340 on track for clinical testing

May 3, 1996

Sankyo macrophage activators claimed as immunostimulants, antineoplastics

May 3, 1996

Milkhaus to initiate phase I testing of LDI-200 in solid tumors

May 3, 1996

Efficacy data for Gonadimmune reported at AACR

May 3, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...